2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
AUTOR(ES)
Hanuš, Lumír
FONTE
The National Academy of Sciences
RESUMO
Two types of endogenous cannabinoid-receptor agonists have been identified thus far. They are the ethanolamides of polyunsaturated fatty acids—arachidonoyl ethanolamide (anandamide) is the best known compound in the amide series—and 2-arachidonoyl glycerol, the only known endocannabinoid in the ester series. We report now an example of a third, ether-type endocannabinoid, 2-arachidonyl glyceryl ether (noladin ether), isolated from porcine brain. The structure of noladin ether was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and was confirmed by comparison with a synthetic sample. It binds to the CB1 cannabinoid receptor (Ki = 21.2 ± 0.5 nM) and causes sedation, hypothermia, intestinal immobility, and mild antinociception in mice. It binds weakly to the CB2 receptor (Ki > 3 μM).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=31108Documentos Relacionados
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
- Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system
- Cannabinoid CB1 Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
- Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
- Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
